These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25539800)

  • 41. Tigecycline sclerotherapy for recurrent pseudotumor in aseptic lymphocyte-dominant vasculitis-associated lesion after metal-on-metal total hip arthroplasty: A case report.
    Lin IH; Tsai CH
    World J Clin Cases; 2021 Dec; 9(34):10696-10701. PubMed ID: 35005003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Development of Third-Generation Tetracycline Antibiotics and New Perspectives.
    Rusu A; Buta EL
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review.
    Yaghoubi S; Zekiy AO; Krutova M; Gholami M; Kouhsari E; Sholeh M; Ghafouri Z; Maleki F
    Eur J Clin Microbiol Infect Dis; 2022 Jul; 41(7):1003-1022. PubMed ID: 33403565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypofibrinogenemia induced by high-dose tigecycline-case report and review of literature.
    Fan Q; Huang W; Weng Y; Xie X; Shi Z
    Medicine (Baltimore); 2020 Oct; 99(43):e22638. PubMed ID: 33120753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of pharmacokinetic/pharmacodynamic ratio on tigecycline clinical response and toxicity in critically ill patients with multidrug-resistant Gram-negative infections.
    Ruiz J; Ramirez P; Villarreal E; Gordon M; Sánchez MÁ; Martín M; Castellanos-Ortega Á
    SAGE Open Med; 2020; 8():2050312120958897. PubMed ID: 32999720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiological and phylogenetic analysis reveals Flavobacteriaceae as potential ancestral source of tigecycline resistance gene tet(X).
    Zhang R; Dong N; Shen Z; Zeng Y; Lu J; Liu C; Zhou H; Hu Y; Sun Q; Cheng Q; Shu L; Cai J; Chan EW; Chen G; Chen S
    Nat Commun; 2020 Sep; 11(1):4648. PubMed ID: 32938927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial Resistance in ESKAPE Pathogens.
    De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients.
    Hu J; Xiao YH; Zheng Y; Lai YX; Fang XL; Fang Q
    Eur J Clin Pharmacol; 2020 Jul; 76(7):913-922. PubMed ID: 32355990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis.
    Zha L; Pan L; Guo J; French N; Villanueva EV; Tefsen B
    Adv Ther; 2020 Mar; 37(3):1049-1064. PubMed ID: 32006240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.
    Aguilera-Alonso D; Escosa-García L; Saavedra-Lozano J; Cercenado E; Baquero-Artigao F
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delirium induced by tigecycline treatment for Acinetobacter baumannii infection: A case report.
    Zheng X; Jiang H; Xue L; Qiu F; Zhu S; Li X
    Medicine (Baltimore); 2019 May; 98(19):e15399. PubMed ID: 31083168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage.
    Xiong Y; Liu W; Huang Q; Wang J; Wang Y; Li H; Fu X
    Sci Rep; 2018 Aug; 8(1):11747. PubMed ID: 30082885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tigecycline application in a 3-month-old infant with multiple drug resistant
    Peng C; Wang X; Zhang J; Jiang Y; Hou X
    Gut Pathog; 2018; 10():25. PubMed ID: 29977345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting mitochondrial respiration selectively sensitizes pediatric acute lymphoblastic leukemia cell lines and patient samples to standard chemotherapy.
    Fu X; Liu W; Huang Q; Wang Y; Li H; Xiong Y
    Am J Cancer Res; 2017; 7(12):2395-2405. PubMed ID: 29312795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia.
    Wu X; Zhao P; Dong L; Zhang X
    Medicine (Baltimore); 2017 Dec; 96(49):e9124. PubMed ID: 29245350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii.
    Fang YQ; Zhan RC; Jia W; Zhang BQ; Wang JJ
    Medicine (Baltimore); 2017 Aug; 96(31):e7703. PubMed ID: 28767605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carbapenem-Resistant Enterobacteriaceae Infections in Children.
    Chiotos K; Han JH; Tamma PD
    Curr Infect Dis Rep; 2016 Jan; 18(1):2. PubMed ID: 26711126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tigecycline : a critical safety review.
    Kaewpoowat Q; Ostrosky-Zeichner L
    Expert Opin Drug Saf; 2015 Feb; 14(2):335-42. PubMed ID: 25539800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tigecycline: a critical update.
    Shakil S; Akram M; Khan AU
    J Chemother; 2008 Aug; 20(4):411-9. PubMed ID: 18676218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW; Neumiller JJ; Setter SM
    Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.